Calithera Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Calithera Biosciences's estimated annual revenue is currently $9.8M per year.
- Calithera Biosciences's estimated revenue per employee is $286,765
- Calithera Biosciences's total funding is $200.9M.
- Calithera Biosciences's current valuation is $39.3M. (January 2022)
Employee Data
- Calithera Biosciences has 34 Employees.
- Calithera Biosciences grew their employee count by -37% last year.
Calithera Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Sr. VP Development | Reveal Email/Phone |
2 | VP Medical Affairs | Reveal Email/Phone |
3 | SVP, Drug Discovery | Reveal Email/Phone |
4 | VP, Clinical Development | Reveal Email/Phone |
5 | VP, Investor Relations and Strategy | Reveal Email/Phone |
6 | VP Business Development | Reveal Email/Phone |
7 | Chief Financial Officer and Secretary | Reveal Email/Phone |
8 | Director, Biology | Reveal Email/Phone |
9 | Director, Head Biometrics | Reveal Email/Phone |
10 | Executive Director, Finance | Reveal Email/Phone |
Calithera Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 673 | 0% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1725 | 2% | N/A | N/A |
#10 | $10.5M | 52 | 4% | N/A | N/A |
What Is Calithera Biosciences?
Calithera is a development stage pharmaceutical company committed to discovering and developing novel small molecule therapeutics for the treatment of cancer. We are applying our scientific expertise to build a pipeline of unique anti- cancer drugs that selectively target metabolic and apoptotic pathways critical to tumor growth and survival.
keywords:N/A
$200.9M
Total Funding
34
Number of Employees
$9.8M
Revenue (est)
-37%
Employee Growth %
$39.3M
Valuation
N/A
Accelerator
Calithera Biosciences News
Calithera Biosciences Inc (CALA) stock is down -82.08% over the last 12 months, and the average rating from Wall Street analysts is a Strong...
Thinking about buying stock in AT&T, Calithera Biosciences, Aterian, Mandiant, or Xerox? InvestorsObserver (PRNewsfoto/InvestorsObserver)...
Calithera Biosciences is a clinical-stage, precision oncology biopharmaceutical company developing targeted therapies to redefine treatment for...
Targeting cancer, differently. Susan M. Molineaux, Ph.D. | Founder, President & Chief Executive Officer NASDAQ: CALA CALITHERA® and the Calithera Logos are trademarks or registered trademarks of Calithera Biosciences, Inc. All rights reserved. Forward-Looking Statements This presentation an ...
Calithera Biosciences, a South San Francisco, CA-based biotechnology company focused on the development of novel cancer therapeutics, completed a $35m Series D financing. The round was led by Adage Capital Partners, LP., with participation from new investors Longwood Fund and two other institut ...
Other Companies in South San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.3M | 34 | 10% | N/A |
#2 | $8.6M | 37 | -3% | N/A |
#3 | $5.7M | 37 | 9% | N/A |
#4 | $10.4M | 37 | 3% | N/A |
#5 | $5.7M | 37 | -18% | N/A |